(MURA) Mural Oncology - Performance -13.1% in 12m
MURA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-39.53%
#55 in Peer-Group
Rel. Strength
25.50%
#5718 in Stock-Universe
Total Return 12m
-13.13%
#77 in Peer-Group
Total Return 5y
-32.11%
#48 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 4.47 USD |
| 52 Week Low | 1.00 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 70.63 |
| Buy/Sell Signal +-5 | 0.54 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: MURA (-13.1%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: MURA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for MURA
| Total Return (including Dividends) | MURA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -0.39% | 3.36% | 5.25% |
| 3 Months | 128.32% | 15.73% | 24.13% |
| 12 Months | -13.13% | -7.02% | 14.15% |
| 5 Years | -32.11% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | MURA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -37.2% | 4.4% | 81% |
| 3 Months | 0.9% | 78.8% | 96.9% |
| 12 Months | -34.3% | -85.8% | 44.9% |
| 5 Years | -63.1% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th50.50 | -3.62% | -5.35% |
| 3 Month | %th96.50 | 97.28% | 83.94% |
| 12 Month | %th62.00 | -6.57% | -23.90% |
| 5 Years | %th66.50 | -44.24% | -52.22% |
FAQs
Does Mural Oncology (MURA) outperform the market?
No,
over the last 12 months MURA made -13.13%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months MURA made 128.32%, while XBI made 15.73%.
Performance Comparison MURA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
MURA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2.3% | -5.6% | -30.7% | -27% |
| US NASDAQ 100 | QQQ | 2.6% | -5.7% | -31.3% | -26% |
| German DAX 40 | DAX | 4.5% | 1% | -42.8% | -42% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 2.5% | -3.6% | -34.1% | -33% |
| Hongkong Hang Seng | HSI | 2.7% | -6.5% | -50.1% | -52% |
| India NIFTY 50 | INDA | 4.2% | -3.9% | -31% | -12% |
| Brasil Bovespa | EWZ | -0.1% | -9.2% | -55.7% | -23% |
MURA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 3.7% | -6.3% | -34.8% | -38% |
| Consumer Discretionary | XLY | 2.8% | -3.6% | -23% | -31% |
| Consumer Staples | XLP | 2% | -1% | -32.3% | -22% |
| Energy | XLE | 2% | -7.5% | -26.6% | -13% |
| Financial | XLF | 1.6% | -5.5% | -35.6% | -43% |
| Health Care | XLV | 2.9% | -2.5% | -23.3% | -9% |
| Industrial | XLI | 2.2% | -4.6% | -38.5% | -38% |
| Materials | XLB | 0.1% | -4.7% | -35.2% | -19% |
| Real Estate | XLRE | 2.4% | -1.4% | -30.4% | -26% |
| Technology | XLK | 1.6% | -9.1% | -33% | -24% |
| Utilities | XLU | 3.4% | -2.2% | -33.9% | -36% |
| Aerospace & Defense | XAR | 4.5% | -7.5% | -49.2% | -62% |
| Biotech | XBI | 1.3% | -3.8% | -17.5% | -6% |
| Homebuilder | XHB | -0.2% | -7.4% | -23.5% | -19% |
| Retail | XRT | -0.2% | -5.4% | -26.4% | -24% |
MURA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 1.4% | -8.83% | -22.3% | -6% |
| Natural Gas | UNG | 11.8% | 9.4% | -13.9% | -11% |
| Gold | GLD | 2.1% | 0.8% | -51.3% | -52% |
| Silver | SLV | 1.3% | -7.3% | -48% | -31% |
| Copper | CPER | 3.3% | -5% | -47.7% | -24% |
MURA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 4.1% | -1.4% | -27.2% | -11% |
| iShares High Yield Corp. Bond | HYG | 3.5% | -2% | -29.6% | -23% |